Research output per year
Research output per year
Personal profile
Headline
PROFESSOR, Medicine, Cardiology
Fingerprint
Dive into the research topics where Robert Sidney Rosenson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Ray, K. K., Oru, E., Rosenson, R. S., Jones, J., Ma, X., Walgren, J., Haupt, A., Verma, S., Gaudet, D., Nicholls, S. J. & Ruotolo, G., 3 May 2025, In: The Lancet. 405, 10489, p. 1594-1607 14 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
Ballantyne, C. M., Gaudet, D., Rosenson, R. S., Hegele, R. A., Zhou, R., Melquist, S., Hellawell, J. & Leeper, N. J., 20 May 2025, In: Journal of the American College of Cardiology. 85, 19, p. 1839-1854 16 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank
Gibson, K., Forrest, I. S., Petrazzini, B. O., Duffy, Á., Park, J. K., Malick, W., Rosenson, R. S., Rocheleau, G., Jordan, D. M. & Do, R., Feb 2025, In: Atherosclerosis. 401, 119103.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Hypertriglyceridemia-induced acute pancreatitis in pregnancy associated with CREB3L3 mutation
Gurevitz, C., Mechanick, J. I., Do, R. & Rosenson, R. S., 1 Jan 2025, In: Journal of Clinical Lipidology. 19, 1, p. 173-177 5 p.Research output: Contribution to journal › Article › peer-review
-
Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry
on behalf of the GOULD Investigators, 15 Feb 2025, In: International Journal of Cardiology. 421, 132916.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
RNA Inhibitor Reduces “Bad Cholesterol” in Patients With Cardiovascular Disease
18/02/25
2 items of Media coverage
Press/Media
-
HMN 2025: RNA inhibitor could successfully cut back excessive -risk ldl cholesterol in sufferers with heart problems t
18/02/25
1 item of Media coverage
Press/Media
-
Olpasiran associated with reducing bad cholesterol in Cardiovascular Disease
17/02/25
1 item of Media coverage
Press/Media
-
Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk
13/02/25
1 item of Media coverage
Press/Media
-
Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk
13/02/25
1 item of Media coverage
Press/Media